Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia

NCT00112554 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

420

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia

Interventions

DRUG: cytarabine
DRUG: laromustine
OTHER: placebo

Sponsor

Vion Pharmaceuticals